Elimination of colonic patches with lymphotoxin β receptor-Ig prevents TH2 cell-type colitis

Journal of Immunology

Volumn 167, Issue 5, 2001, Pages 2781-2790

  Dohi, T ^a   Rennert, P D ^a   Fujihashi, K ^a   Kiyono, H ^a   Shirai, Y ^a   Kawamura, Y I ^a   Browning, J L ^a   McGhee, J R ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HYBRID PROTEIN; IMMUNOGLOBULIN G; LYMPHOTOXIN; LYMPHOTOXIN BETA RECEPTOR IMMUNOGLOBULIN G FUSION PROTEIN; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; COLITIS; COLON ULCER; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE SEVERITY; INTESTINE LYMPHATIC TISSUE; KNOCKOUT MOUSE; LYMPHOID HYPERPLASIA; MOUSE; NONHUMAN; PATHOGENESIS; PEYER PATCH; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; TREATMENT OUTCOME;

EID: 0035451424     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.5.2781     Document Type: Article

References (47)

1. Hapten-induced model of chronic inflammation and ulceration in the rat colon
2. Antibodies to interleukin-12 abrogate established experimental colitis in mice
3. Hapten-induced model of murine inflammatory bowel disease: Mucosa immune responses and protection by tolerance
4. Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance
5. Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice
6. Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses
7. Mice deficient in Th1-type and Th2-type cytokines develop distinct forms of hapteninduced colitis
8. + lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease
9. Characterization of cytokine expression in the rectal mucosa of ulcerative colitis: Correlation with disease activity
10. Development and maturation of secondary lymphoid tissues
11. B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin α-dependent fashion
12. Lymph node genesis is induced by signaling through the lymphotoxin β receptor
13. The lymphotoxin β receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues
14. Surface lymphotoxin αβ complex is required for the development of peripheral lymphoid organs
15. Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization
16. Characterization of lymphotoxin-αβ complexes on the surface of mouse lymphocytes
17. Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice
18. The sequential role of lymphotoxin and B cells in the development of splenic follicles
19. Mature follicular dendritic cell networks depend on expression of lymphotoxin β receptor by radioresistant stromal cells and of lymphotoxin β and tumor necrosis factor by B cells
20. Lymph node germinal centers form in the absence of follicular dendritic cell networks
21. Turning off follicular dendritic cells
22. Lymphotoxin αβ and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen
23. Multiple deficiencies underlie NK cell inactivity in lymphotoxin-α gene-targeted mice
24. The requirement of membrane lymphotoxin for the presence of dendritic cells in lymphoid tissues
25. Reversal of virus-induced systemic shock and respiratory failure by blockade of the lymphotoxin pathway
26. Lymphotoxin-β-deficient mice show defective antiviral immunity
27. Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis
28. Mouse lymphotoxin-β receptor: Molecular genetics, ligand binding, and expression
29. Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cells responses
30. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion
31. γδ T cell-deficient mice have impaired mucosal immunoglobulin A responses
32. + T cells that secrete IFN-γ and IL-5
33. Polarized Th2 cytokine expression by both mucosal γδ and αβ T cells
34. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella
35. + T cells for helper activity
36. Alternate mucosal immune system: Organized Peyer's patches are not required for IgA responses in the gastrointestinal tract
37. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice
38. + T cells
39. Tumor necrosis factor a antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis
40. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
41. Randomised controlled trial of CDP571 antibody to tumour necrosis factor-α in Crohn's disease
42. 'M' cells in the follicle-associated epithelium of the human colon
43. Lymphoglandular complexes of the colon: Structure and distribution
44. Experimental models of inflammatory bowel disease
45. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)
46. T cell specificity and cross reactivity towards enterobacteria, Bacteriodes, Bifidobacterium, and antigens from resident intestinal flora in humans
47. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria